Document Detail

Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.
MedLine Citation:
PMID:  22728949     Owner:  NLM     Status:  MEDLINE    
Chronic intermittent hypoxia (CIH) raises arterial pressure, impairs vasodilator responsiveness, and increases circulating angiotensin II (Ang II); however, the role of Ang II in CIH-induced vascular dysfunction is unknown. Rats were exposed to CIH or room air (NORM), and a subset of these animals was treated with losartan (Los) during the exposure period. After 28 days, vasodilatory responses to acetylcholine or nitroprusside were measured in isolated gracilis arteries. Superoxide levels and Ang II receptor protein expression were measured in saphenous arteries. After 28 days, arterial pressure was increased and acetylcholine-induced vasodilation was blunted in CIH vs. NORM, and this was prevented by Los. Responses to nitroprusside and superoxide levels did not differ between CIH and NORM. Expression of AT(2)R was decreased and the AT(1)R:AT(2)R ratio was increased in CIH vs. NORM, but this was unaffected by Los. These results indicate that the blood pressure elevation and endothelial dysfunction associated with CIH is dependent, at least in part, on RAS signaling.
Noah J Marcus; Nathan R Philippi; Cynthia E Bird; Yu-Long Li; Harold D Schultz; Barbara J Morgan
Related Documents :
22801399 - Increased vascular tone due to sympathovagal imbalance in normotensive and prehypertens...
2072809 - Effects of acute hypoxemia on responses to dopamine and dobutamine in neonatal swine.
9074709 - Aortic blood momentum--the more the better for the ejecting heart in vivo?
8964109 - Physiological and biochemical evidence for coordinate increases in muscarinic receptors...
2426829 - A qualitative analysis of pulsatile perfusion: effects on cortisol response to cardiopu...
22672299 - Synergic effects of levamlodipine and bisoprolol on blood pressure reduction and organ ...
15647779 - The controversial role of serum uric acid in essential hypertension: relationships with...
24797919 - Black tio2 nanotubes: co-catalyst free open-circuit hydrogen generation.
4022579 - Trabeculodialysis for inflammatory glaucoma in children and young adults.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-06-21
Journal Detail:
Title:  Respiratory physiology & neurobiology     Volume:  183     ISSN:  1878-1519     ISO Abbreviation:  Respir Physiol Neurobiol     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-31     Completed Date:  2013-01-04     Revised Date:  2013-08-19    
Medline Journal Info:
Nlm Unique ID:  101140022     Medline TA:  Respir Physiol Neurobiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  67-74     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier B.V. All rights reserved.
John Rankin Laboratory of Pulmonary Medicine, University of Wisconsin, Madison, WI 53706-1532, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetylcholine / pharmacology
Angiotensin II Type 1 Receptor Blockers / pharmacology*
Anoxia / physiopathology*
Arteries / drug effects,  physiopathology
Endothelium, Vascular / drug effects,  physiopathology*
Losartan / pharmacology
Nitroprusside / pharmacology
Rats, Sprague-Dawley
Receptor, Angiotensin, Type 1 / physiology*
Receptors, Angiotensin / biosynthesis
Signal Transduction / drug effects,  physiology
Superoxides / analysis
Vascular Resistance / drug effects,  physiology
Vasodilation / drug effects,  physiology
Grant Support
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Receptor, Angiotensin, Type 1; 0/Receptors, Angiotensin; 11062-77-4/Superoxides; 114798-26-4/Losartan; 15078-28-1/Nitroprusside; 51-84-3/Acetylcholine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neurotransmitter profiles in fish gills: Putative gill oxygen chemoreceptors.
Next Document:  Nutritional quality of Australian breakfast cereals - are they improving?